HIGHLIGHTS
- who: Maria Guarino and collaborators from the Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy have published the research work: Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma, in the Journal: (JOURNAL)
- what: The aim of this review is to furnish an overview of the risks of SARS-CoV-2 infection in HCC patients and of the impact of the pandemic on HCC patient management with regard to surveillance programs, diagnosis, and treatment. Nonetheless, TACE is a palliative treatment to reach cytoreduction, with the main purpose . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.